Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01
Ruth Payne, Kathryn H. Milne, Sean C. Elias, et al.
The Journal of Infectious Diseases (2016) Vol. 213, Iss. 11, pp. 1743-1751
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Malaria Vaccines: Recent Advances and New Horizons
Simon J. Draper, Brandon K. Sack, C. Richter King, et al.
Cell Host & Microbe (2018) Vol. 24, Iss. 1, pp. 43-56
Open Access | Times Cited: 299
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy, J. Patrick Gorres
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 212
Challenges and strategies for developing efficacious and long-lasting malaria vaccines
James G. Beeson, Liriye Kurtovic, Carlota Dobaño, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 474
Open Access | Times Cited: 181
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett, et al.
Med (2021) Vol. 2, Iss. 6, pp. 701-719.e19
Open Access | Times Cited: 122
Malaria vaccines: the 60-year journey of hope and final success—lessons learned and future prospects
Amal A. El‐Moamly, Mohamed Aly El-Sweify
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 46
Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth Payne, Sarah E. Silk, Sean C. Elias, et al.
JCI Insight (2017) Vol. 2, Iss. 21
Open Access | Times Cited: 133
Controlled Human Malaria Infection: Applications, Advances, and Challenges
Danielle I. Stanisic, James McCarthy, Michael F. Good
Infection and Immunity (2017) Vol. 86, Iss. 1
Open Access | Times Cited: 129
A controlled human malaria infection model enabling evaluation of transmission-blocking interventions
Katharine A. Collins, Claire Wang, Matthew Adams, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 4, pp. 1551-1562
Open Access | Times Cited: 105
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth Payne, Sarah E. Silk, Sean C. Elias, et al.
JCI Insight (2017) Vol. 2, Iss. 12
Open Access | Times Cited: 95
Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium
Camila H. Coelho, Justin Doritchamou, Irfan Zaidi, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 89
Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites
Roos M. de Jong, Surafel K. Tebeje, Lisette Meerstein‐Kessel, et al.
Immunological Reviews (2019) Vol. 293, Iss. 1, pp. 190-215
Open Access | Times Cited: 82
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, et al.
Med (2023) Vol. 4, Iss. 10, pp. 668-686.e7
Open Access | Times Cited: 27
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Mimi M. Hou, Jordan R. Barrett, Yrene Themistocleous, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 704
Open Access | Times Cited: 24
Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
Jing Jin, Richard Tarrant, Emma Bolam, et al.
npj Vaccines (2018) Vol. 3, Iss. 1
Open Access | Times Cited: 69
Controlled Human Malaria Infection of Healthy Adults With Lifelong Malaria Exposure to Assess Safety, Immunogenicity, and Efficacy of the Asexual Blood Stage Malaria Vaccine Candidate GMZ2
Jean Claude Dejon‐Agobé, Ulysse Ateba-Ngoa, Albert Lalremruata, et al.
Clinical Infectious Diseases (2018) Vol. 69, Iss. 8, pp. 1377-1384
Open Access | Times Cited: 69
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
P. Srinivasan, G. Christian Baldeviano, Kazutoyo Miura, et al.
npj Vaccines (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 63
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
Robert J. Ragotte, Matthew K. Higgins, Simon J. Draper
Trends in Parasitology (2020) Vol. 36, Iss. 6, pp. 545-559
Open Access | Times Cited: 63
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system
Kathryn A. Hjerrild, Jing Jin, Katherine E. Wright, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 61
Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
Navneet Arora, Lokhesh C Anbalagan, Ashok Kumar Pannu
Risk Management and Healthcare Policy (2021) Vol. Volume 14, pp. 1033-1039
Open Access | Times Cited: 53
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
Yara‐Natalie Abo, Euzebiusz Jamrozik, James McCarthy, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. e533-e546
Open Access | Times Cited: 17
Structure-based design of a strain transcending AMA1-RON2L malaria vaccine
Palak Patel, Thayne H. Dickey, Ababacar Diouf, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
Irene N. Nkumama, Rodney Ogwang, Dennis Odera, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1215-1224.e6
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top